These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Neutrophil gelatinase-associated lipocalin (NGAL) in inflammatory bowel disease: association with pathophysiology of inflammation, established markers, and disease activity. Oikonomou KA, Kapsoritakis AN, Theodoridou C, Karangelis D, Germenis A, Stefanidis I, Potamianos SP. J Gastroenterol; 2012 May; 47(5):519-30. PubMed ID: 22200942 [Abstract] [Full Text] [Related]
7. Serum Neutrophil Gelatinase B-associated Lipocalin and Matrix Metalloproteinase-9 Complex as a Surrogate Marker for Mucosal Healing in Patients with Crohn's Disease. de Bruyn M, Arijs I, De Hertogh G, Ferrante M, Van Assche G, Rutgeerts P, Vermeire S, Opdenakker G. J Crohns Colitis; 2015 Dec; 9(12):1079-87. PubMed ID: 26351381 [Abstract] [Full Text] [Related]
16. Evaluation of serum neutrophil gelatinase-associated lipocalin (NGAL), asymmetric dimethylarginine (ADMA) and symmetric dimethylarginine (SDMA) levels, and their relations with disease type and activity in inflammatory bowel diseases. Korkmaz H, Asıl M, Temel T, Öztürk B, Kebapçılar L. Turk J Med Sci; 2021 Oct 21; 51(5):2403-2412. PubMed ID: 33984894 [Abstract] [Full Text] [Related]
18. Can serum NGAL levels be used as an inflammation marker on hemodialysis patients with permanent catheter? Yigit IP, Celiker H, Dogukan A, Ilhan N, Gurel A, Ulu R, Aygen B. Ren Fail; 2015 Feb 21; 37(1):77-82. PubMed ID: 25347233 [Abstract] [Full Text] [Related]